BB Biotech's market cap is currently CHF2.01B. The company's EPS TTM is CHF-1.835; its P/E ratio is 20.77; and it has a dividend yield of 4.91%. BB Biotech is scheduled to report earnings on July 25, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
